NCLH vs TSHA · P/E 16, rev $4.97B vs $640.7M cap
Norwegian Cruise Line Holdings Ltd (NCLH) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the NCLH and TSHA stock pages for the full models.
Not investment advice.